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The studies described in this thesis were carried out to find out whether there
is evidence to support the hypothesis that asthma (and bronchial hyper-
responsiveness in particular) is associated with a dysfunction in the systems that
regulate cellular activities: the signal transduction systems. This hypothesis is
based on the association that is found between asthma and an enhancement of
cellular activify (both in vivo and in vitro) observed in several types of
peripheral blood cells from patients with asthma.
Theoretically, these enhanced activities could be caused either by an
impairment of signal transduction systems that decrease cellular activity or by
an enhancement of systems that increase cellular activity. In particular, signal
transduction system in mononuclear blood cells were examined in the studies
described in this thesis, because these cells are important regulators of the
inflammatory process in the airways underlying bronchial hyperresponsiveness.
First of all the former possibility was examined. This study, described in
Chapter 2, shows that the adenylyl cyclase system, the main signal transduction
system involved in a decrease of cellular activity, functions normally in
mononuclear cells from patients with asthma, as long as these patients are in a
stable condition (defined as having no history of respiratory tract infections or
acute asthmatic attacks for at least 2 months). An impairment in adenylyl
cyclase activity, including heterologous and homologous desensitization, is only
observed after inhalation of allergen by these patients. Desensitization takes
already place within 3 hours after challenge, implying that an irnpairment of
adenylyl cyclase could be involved in the enhancement of bronchiar hyper-
responsiveness that can be observed in asthmatics after allergen challenge.
This could be mediated by alterations in the production of cytokines by
mononuclear cells - a process that is controlled by adenylyl cyclase - leading
to (more) inflammation of the airways. Alternatively, desensitizationof adenylyl
cyclase could be generalized, and therefore might be present in bronchial
smooth muscle cells as well. Because adenylyl cyclase is known to control
relaxation of smooth muscles this might cause a disturbed balance between
contraction and relaxation of bronchial muscles in favour of contraction, thereby
increasing the sensitivity of the smooth muscles to bronchoconstrictive stimuli.
Next the second possible mechanism causing enhanced cellular activities








cellular activities. For this purpose two systems, phospholipase C and
phospholipase A,, were examined by means of the production of 1,2-diacyl-
glycerol and arachidonic acid respectively. This study, described in Chapter 3,
shows that the activity of both phospholipase C and phospholipase A, in
mononuclear cells from patients with asthma (who are in a stable condition) is
not anomalous compared to healthy control subjects. In contrast to adenylyl
cyclase both phospholipase C and phospholipase A, turned out not to be affected
by allergen challenge.
At this point in the study it had to be concluded that a dysfunction of a
single signal transduction system is not likely as a mechanism underlying
asthma and bronchial hyperresponsiveness.
Knowing that the various signal transduction systems can influence each
others activities a subsequent study was carried out to gain more insight in the
biochemical details of one particular form of this so-called cross-talk: the effect
of cell-activating stimuli on the functioning of adenylyl cyclase. This srudy,
described in Chapter 4, shows that stimuli that activate the cell (e.g. through
phospholipase C) simultaneously increase the response of adenylyl cyclase to
stimuli that activate adenylyl cyclase. This phenomenon is called potentiation
of adenylyl cyclase. It appeared that potentiation of adenylyl cyclase is a
transient process that probably involves the activation of the calcium-dependent
protein calmodulin as potentiation could be inhibited by blocking calmodulin.
Since adenylyl cyclase is the main signal transduction system involved in
deactivation of cellular activity, potentiation of this system by cell activating
signals is most likely an important physiological mechanism to prevent cells
Írom becoming 'over st imulated'.
Finally potentiation of adenylyl cyclase was examined in cells from patients
with asthma. After all, a defect in this feedback mechanism could be a
nrolecular explanation for the enhanced sensitivity to stimuli that is found in the
airway as well in blood cells from patients with asthma. This study, described
in Chapter 5, shows that potentiation of adenylyl cyclase is significantly lower
in cells from asthmatics than in cells from healthy controls. In addition, the
residual amount of potentiation in cells from asthmatics correlates with the
degree of bronchial hyperresponsiveness in these patients in a remarkably strong




























transduction and this clinical parameter of asthma. Two possible mechanisms
underlying this correlation are discussed.
In Chapter 6 the hypothesis of this thesis - asthma is associated with a
dysfunction in signal transduction systems - is evaluated. On the basis of the
data described in the preceding chapters, we conclude that in patients with
asthma who are in a stable condition it is not the activity of a single signal
transduction systems that is deficient, but a particular form of cross-talk
between signal transduction systems: potentiation of the adenylyl cyclase
system. This defect is believed to result in a lack of adequate feedback of
activating stimuli. This might lead, through altered cytokine production, to an
influx of inflammatory cells into the airways, resulting in bronchial hyper-
responsiveness. Alternatively, the observed defect of potentiation may be
generalized, and may therefore be present in airway smooth muscle as well. As
a consequence, bronchoconstrictive stimuli would not be counteracted
adequately, resulting in a disturbed balance between contraction and relaxation
of bronchial smooth muscle.
Additionally, allergen challenge causes an impairment of the adenylyl
cyclase system itself. This will further affect this signal transduction system in
its function of controlling cellular activity.
128
